Page 25 - Read Online

Manrique et al. Microbiome Res Rep 2024;3:23 https://dx.doi.org/10.20517/mrr.2023.80 Page 19 of 20

enriching nutrients and depleting microbial metabolites. Nat Commun 2023;14:5094. DOI PubMed PMC
123. Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol Rev
2017;279:90-105. DOI PubMed PMC
124. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated
antibiotic perturbation. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4554-61. DOI PubMed PMC
125. Relman DA. The human microbiome: ecosystem resilience and health. Nutr Rev 2012;70 Suppl 1:S2-9. DOI PubMed PMC
126. Saha S, Tariq R, Tosh PK, Pardi DS, Khanna S. Faecal microbiota transplantation for eradicating carriage of multidrug-resistant
organisms: a systematic review. Clin Microbiol Infect 2019;25:958-63. DOI PubMed
127. Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: from a murky past to a
bright future? Cell Metab 2021;33:1098-110. DOI PubMed
128. Groen AK, Nieuwdorp M. An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and
metabolic diseases. EMBO Mol Med 2017;9:1-3. DOI PubMed PMC
129. Khoruts A, Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.
Immunol Lett 2014;162:77-81. DOI PubMed PMC
130. Friedman ND, Pollard J, Stupart D, et al. Prevalence of Clostridium difficile colonization among healthcare workers. BMC Infect Dis
2013;13:459. DOI PubMed PMC
131. Cold F, Baunwall SMD, Dahlerup JF, Petersen AM, Hvas CL, Hansen LH. Systematic review with meta-analysis: encapsulated
faecal microbiota transplantation - evidence for clinical efficacy. Therap Adv Gastroenterol 2021;14:17562848211041004. DOI
PubMed PMC
132. Baunwall SMD, Lee MM, Eriksen MK, et al. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an
updated systematic review and meta-analysis. EClinicalMedicine 2020;29-30:100642. DOI PubMed PMC
133. Seekatz AM, Theriot CM, Rao K, et al. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota
transplantation in patients with recurrent Clostridium difficile infection. Anaerobe 2018;53:64-73. DOI PubMed PMC
134. Shetty SA, Hugenholtz F, Lahti L, Smidt H, de Vos WM. Intestinal microbiome landscaping: insight in community assemblage and
implications for microbial modulation strategies. FEMS Microbiol Rev 2017;41:182-99. DOI PubMed PMC
135. Costello SP, Conlon MA, Vuaran MS, Roberts-Thomson IC, Andrews JM. Faecal microbiota transplant for recurrent Clostridium
difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data. Aliment Pharmacol Ther
2015;42:1011-8. DOI PubMed
136. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for
relapsing Clostridium difficile infection. JAMA 2014;312:1772-8. DOI PubMed
137. Kao D, Roach B, Silva M, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent
Clostridium difficile infection: a randomized clinical trial. JAMA 2017;318:1985-93. DOI PubMed PMC
138. Mehta SR, Yen EF. Microbiota-based therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Transl Res
2021;230:197-207. DOI PubMed
139. de Groot P, Nikolic T, Pellegrini S, et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a
randomised controlled trial. Gut 2021;70:92-105. DOI PubMed PMC
140. Gangwani MK, Aziz M, Aziz A, et al. Fresh versus frozen versus lyophilized fecal microbiota transplant for recurrent Clostridium
difficile infection: a systematic review and network meta-analysis. J Clin Gastroenterol 2023;57:239-45. DOI
141. Saha S, Khanna S. Stool banking for fecal microbiota transplantation: ready for prime time? Hepatobiliary Surg Nutr 2021;10:110-2.
DOI PubMed PMC
142. Pérez-Nadales E, Cano Á, Recio M, et al. Randomised, double-blind, placebo-controlled, phase 2, superiority trial to demonstrate the
effectiveness of faecal microbiota transplantation for selective intestinal decolonisation of patients colonised by carbapenemase-
producing Klebsiella pneumoniae (KAPEDIS). BMJ Open 2022;12:e058124. DOI PubMed PMC
143. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel
diseases. Cell Host Microbe 2008;3:417-27. DOI PubMed PMC
144. Manrique P, Bolduc B, Walk ST, van der Oost J, de Vos WM, Young MJ. Healthy human gut phageome. Proc Natl Acad Sci U S A
2016;113:10400-5. DOI PubMed PMC
145. Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and
shared responses. Nat Commun 2017;8:1784. DOI PubMed PMC
146. Schmidt TSB, Li SS, Maistrenko OM, et al. Drivers and determinants of strain dynamics following fecal microbiota transplantation.
Nat Med 2022;28:1902-12. DOI PubMed PMC
147. Conceição-Neto N, Deboutte W, Dierckx T, et al. Low eukaryotic viral richness is associated with faecal microbiota transplantation
success in patients with UC. Gut 2018;67:1558-9. DOI PubMed PMC
148. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial
tumors. Science 2018;359:91-7. DOI
149. Park SY, Seo GS. Fecal microbiota transplantation: is it safe? Clin Endosc 2021;54:157-60. DOI PubMed PMC
150. Jiang ZD, Jenq RR, Ajami NJ, et al. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product
compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial. PLoS One
2018;13:e0205064. DOI PubMed PMC